atropine has been researched along with moxifloxacin in 9 studies
| Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) |
|---|---|---|---|---|---|
| 26,711 | 1,259 | 1,697 | 3,157 | 552 | 1,690 |
| Protein | Taxonomy | atropine (IC50) | moxifloxacin (IC50) |
|---|---|---|---|
| DNA gyrase subunit B | Staphylococcus aureus | 5.1033 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 1.4 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 1.4 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 0.8 | |
| DNA gyrase subunit A | Staphylococcus aureus | 7.25 | |
| DNA gyrase subunit B | Mycobacterium tuberculosis H37Rv | 8.525 | |
| DNA gyrase subunit A | Mycobacterium tuberculosis H37Rv | 8.66 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chandrika, TN; Katta, KR; Mansoori, T; Reddy, AK; Srirampur, A | 1 |
| Mansoori, T; Reddy, AK; Sistla, A; Srirampur, A; Suresh, N | 1 |
1 review(s) available for atropine and moxifloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for atropine and moxifloxacin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Management of Nocardia Interface Keratitis After Descemet Membrane Endothelial Keratoplasty.
Topics: Administration, Ophthalmic; Aged; Anti-Bacterial Agents; Atropine; Ciprofloxacin; Combined Modality Therapy; Descemet Stripping Endothelial Keratoplasty; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Keratitis; Male; Moxifloxacin; Nocardia asteroides; Nocardia Infections; Ophthalmic Solutions; Reoperation; Retrospective Studies; Visual Acuity | 2019 |
Retrocorneal abscess: an unusual presentation of Nocardia keratitis after Descemet's stripping endothelial keratoplasty.
Topics: Abscess; Aged, 80 and over; Anti-Bacterial Agents; Antihypertensive Agents; Atropine; Corneal Diseases; Descemet Stripping Endothelial Keratoplasty; Eye Infections, Bacterial; Female; Humans; Keratitis; Microbial Sensitivity Tests; Moxifloxacin; Mydriatics; Nocardia; Nocardia Infections; Postoperative Complications; Slit Lamp Microscopy; Tomography, Optical Coherence; Visual Acuity | 2020 |